力世紀(00860.HK)旗下城市物流車料於2022年起開始生產
力世紀(00860.HK)公布,中國國際進口博覽會上首次展示城市物流車,為實現低成本製造,城市物流車可作為組裝套件運送到東南亞、中東和北非等地,然後在當地的微型工廠組裝,有望為出行行業創造就業機會,預計於2022年開始生產。
另外,力世紀附屬公司GLM株式會社研發的電動代步車,目標客群為長者,目前正在進一步開發,期望在2022年底實現商業化。力世紀與日本半導體和電子元件製造商ROHM Co., Ltd.共同研發的800V碳化矽雙逆變器系統,在12分鐘內可充電達到80%的電量,公司目標是至2021年底將其進一步降低至6分鐘。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.